Design And End Points Of Clinical Trials For Patients With Progressive Prostate Cancer And Castrate Levels Of Testosterone: Recommendations Of The Prostate Cancer Clinical Trials Working Group

·2008·DOI

Role in the Field

Abstract

Citations

1,976

Year

2008

PageRank

4.6 / 10

Relative influence (log-scaled)

Design And End Points Of Clinical Trials For Patients With Progressive Prostate Cancer And Castrate Levels Of Testosterone: Recommendations Of The Prostate Cancer Clinical Trials Working Group | Manumap